Evidence map›Paper›PMID 40240492›Full record

ArticleScientific reports2025

Hypoxia LUAD H1975 cell-derived exosomal miR-671-3p promotes angiogenesis via regulating KLF2-VEGFR2 axis.

Kun Liu, Yi Wang, Qisen Li, Yujue Wang, Jinrui Liu, Jintao Zhou, Feiyu Song, Zhongyi Cong, Zhe Wang, Ning Kong

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kun LiuDepartment of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, ChangChun, China.
Yi WangDepartment of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, ChangChun, China. wangyi@jlu.edu.cn.
Qisen LiDepartment of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, ChangChun, China.
Yujue WangDepartment of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, ChangChun, China.
Jinrui LiuDepartment of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, ChangChun, China.
Jintao ZhouDepartment of Thoracic Surgery, The First Hospital of Jilin University, Changchun, China.
Feiyu SongJilin Connell Pharmaceutical Company, Changchun, China.
Zhongyi CongDepartment of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, ChangChun, China.
Zhe WangBeijing University of Chinese Medicine, Beijing, China.
Ning KongDepartment of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, ChangChun, China. kongning@jlu.edu.cn.

Funding

Basic scientific research project foundation of Beijing University of Chinese Medicine 2024-JYB-PY-021Natural Science Foundation of Jilin Province YDZJ202401313ZYTSthe China Postdoctoral Science Foundation 2024M750262
6 · The paper itself

Abstract

For solid tumors, hypoxia is associated with disease aggressiveness and poor outcomes. In addition to undergoing broad intracellular molecular and metabolic adaptations, hypoxic tumor cells extensively communicate with their microenvironments to facilitate conditions favorable for their survival, growth, and metastasis. This communication is mediated by diverse secretory factors, including exosomes (extracellular vesicles of endosomal origin). Exosomal cargo is altered considerably by hypoxia, with significant impacts on tumor-cell communication with both local and distant microenvironments. Exosomes released by cancer cells influence the tumor environment to accelerate metastasis. While tumor-derived exosomes have been identified as a major driver of premetastatic niche formation at distant sites, this mechanism in lung adenocarcinoma (LUAD) remains unclear. We found that miR-671-3p in exosomes derived from H1975 under hypoxic conditions target Krüppel-like factor 2 (KLF2) to regulate VEGFR2 expression in endothelial cells to promote angiogenesis. In addition, miR-671-3p is expressed at high levels in circulating exosomes isolated from patients with LUAD. Our study suggests that exosome miR-671-3p is involved in the formation of premetastatic niche and may serve as a blood-based biomarker for LUAD metastasis.

Indexed as

Adenocarcinoma of LungExosomesKruppel-Like Transcription FactorsLung NeoplasmsMicroRNAsNeovascularization, PathologicVascular Endothelial Growth Factor Receptor-2AngiogenesisCell Line, TumorGene Expression Regulation, NeoplasticHumansHuman Umbilical Vein Endothelial CellsSignal TransductionTumor MicroenvironmentKDR protein, humanKLF2 protein, humanKruppel-Like Transcription FactorsMicroRNAsVascular Endothelial Growth Factor Receptor-2AngiogenesisExosomeHypoxiaLUADmiR-671-3pPremetastatic niche

Identifiers

PMID40240492
PMCPMC12003721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.